Neurootological differential therapy for vertigo patients.

Area of Science:

• Neurootology
• Neurology
• Otolaryngology

Background:

• Neurootological complaints like dizziness, hearing loss, and tinnitus often require pharmacological intervention.
• Accurate diagnosis is crucial for effective, supportive treatment of vertigo patients.

Purpose of the Study:

• To outline the use of a computer-based expert system, Clamedex, for neurootological diagnosis.
• To describe the development of individualized, case-oriented drug therapies based on diagnostic findings.

Main Methods:

• Utilizing Clamedex for diagnosis through patient history, otolaryngological inspection, and various tests (ENG, calorics, CCG, evoked potentials).
• Designing drug therapy based on functional topodiagnostics and effects on the equilibrium regulating network.
• Monitoring patients with regular neurootometric follow-up investigations.

Main Results:

• Clamedex facilitates comprehensive neurootological diagnosis.
• Individualized drug therapies can be tailored to specific patient needs and lesion topodiagnostics.
• Supportive therapies may include drugs that increase cerebral blood flow, enhance blood-brain barrier penetration, boost neuronal metabolism, or stabilize neurotransmitters.

Conclusions:

• The Clamedex system provides a robust knowledge base for diagnosing neurootological disorders.
• Personalized pharmacotherapy, guided by expert systems and functional diagnostics, is key to managing vertigo and associated symptoms.
• A systematic approach combining advanced diagnostics and targeted drug therapy improves patient outcomes.